Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-25 4:12 pm Purchase |
2024-03-15 | 13G | REV Group, Inc. REVG |
Citadel Advisors LLC | 2,697,273 5.200% |
2,697,273 (New Position) |
Filing History |
| 2024-03-22 4:43 pm Purchase |
2024-03-12 | 13G | Cummins Inc. CMI |
Citadel Advisors LLC | 263,557 0.200% |
263,557 (New Position) |
Filing History |
| 2024-03-18 4:13 pm Purchase |
2024-03-08 | 13G | Atara Biotherapeutics, Inc. ATRA |
Citadel Advisors LLC | 261,325 6.400% |
261,325 (New Position) |
Filing History |
| 2024-02-23 4:01 pm Purchase |
2024-02-13 | 13G | Helix Acquisition Corp. II HLXB |
Citadel Advisors LLC | 1,322,155 7.000% |
1,322,155 (New Position) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 4,286,927 7.900% |
1,390,392 (+48.00%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Citadel Advisors LLC | 230,620 0.200% |
-142,287 (-38.16%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Citadel Advisors LLC | 1,027,956 6.000% |
-3 (-0.00%) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
Citadel Advisors LLC | 426,857 0.600% |
426,857 (New Position) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Citadel Advisors LLC | 1,600,768 5.800% |
6,832 (+0.43%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Groupon, Inc. GRPN |
Citadel Advisors LLC | 1,273,880 4.000% |
-70,624 (-5.25%) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Allurion Technologies Inc. ALUR |
Citadel Advisors LLC | 102,549 5.100% |
264 (+0.26%) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Intuitive Machines, Inc. LUNR |
Citadel Advisors LLC | 843,505 3.900% |
843,505 (New Position) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Appreciate Holdings, Inc. SFRT |
Citadel Advisors LLC | 965,611 5.400% |
-154,481 (-13.79%) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 6,649,442 6.800% |
685,642 (+11.50%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 95,356 3.600% |
-84,674 (-47.03%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Clene Inc. CLNN |
Citadel Advisors LLC | 302,516 4.500% |
-78,703 (-20.65%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Applied Optoelectronics, Inc. AAOI |
Citadel Advisors LLC | 506,340 1.200% |
-1,324,593 (-72.35%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Citadel Advisors LLC | 3,276 0.000% |
-1,558,705 (-99.79%) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
Citadel Advisors LLC | 2,880 0.000% |
2,880 (New Position) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | FIGS, Inc. FIGS |
Citadel Advisors LLC | 611,989 0.400% |
-8,605,659 (-93.36%) |
Filing History |